Loading…

Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study

Summary Objective  To investigate the risk of hypothyroidism after radioiodine (131I) treatment for hyperfunctioning thyroid nodules. Design  Retrospective analysis of patients treated with 131I for hyperfunctioning thyroid nodules and followed up for a maximum of 20 years. Patients  A total of 346...

Full description

Saved in:
Bibliographic Details
Published in:Clinical endocrinology (Oxford) 2005-03, Vol.62 (3), p.331-335
Main Authors: Ceccarelli, Claudia, Bencivelli, Walter, Vitti, Paolo, Grasso, Lucia, Pinchera, Aldo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Objective  To investigate the risk of hypothyroidism after radioiodine (131I) treatment for hyperfunctioning thyroid nodules. Design  Retrospective analysis of patients treated with 131I for hyperfunctioning thyroid nodules and followed up for a maximum of 20 years. Patients  A total of 346 patients treated with 131I in the years 1975–95, for a single hyperfunctioning nodule. Measurements  Hypothyroidism was defined as TSH levels > 3·7 mU/l. Kaplan–Meier survival analysis was used to analyse permanence of euthyroidism after 131I. A stepwise Cox proportional hazard model was used to identify factors influencing the progression to hypothyroidism. Results  The cumulative incidence of hypothyroidism was 7·6% at 1 year, 28% at 5 years, 46% at 10 years and 60% at 20 years. Age (P 
ISSN:0300-0664
1365-2265
DOI:10.1111/j.1365-2265.2005.02218.x